Ajay Piramal Vijay Shah India city Mumbai hospital covid-19 pandemic medicines Ajay Piramal Vijay Shah India city Mumbai

Piramal Glass sees surge in vial demand due to COVID-19


BENGALURU : India's Piramal Glass Pvt Ltd has seen a 30% jump in sales of specialty vials used to bottle medicines in the June quarter, led by a surge in demand as more drugs are being made to combat the COVID-19 pandemic, a senior executive told Reuters.The privately held Mumbai-based firm, part of Indian billionaire Ajay Piramal's drugs-to-financial services conglomerate, is projecting a 30% bump in revenue from Type 1 borosilicate glass vials in 2020-21, Piramal Glass Vice-Chairman Vijay Shah said last week."There has been an upsurge in demand because of some adjunct therapies being used in hospitals for COVID patients," Shah said.Shah did not specify revenue figures for Piramal's vials business, but assured it was in a position to..

All news from livemint.com

The website covid-19.rehab is not a news writer, but just an aggregator. The site publishes announcements of the materials taken from the open sources. The news source is indicated at the beginning and at the end of the announcement. As a part of the fight against fakes, you can send a complaint on the news, and we will consider your complaint as soon as possible.

Related News

Breaking news
Disney World Reopens in Florida While Coronavirus Cases Rise - See Photos
NJ reports another 49 virus-related deaths; toll now 13,578
Trump undercuts health experts — again — in schools debate